SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-18-021286
Filing Date
2018-08-10
Accepted
2018-08-10 16:30:19
Documents
3
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A bold-10qa_20180331.htm 10-Q/A 111523
2 EX-31.1 bold-ex311_6.htm EX-31.1 8560
3 EX-31.2 bold-ex312_7.htm EX-31.2 8551
  Complete submission text file 0001564590-18-021286.txt   129666
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37833 | Film No.: 181009216
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences